切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2021, Vol. 10 ›› Issue (06) : 654 -658. doi: 10.3877/cma.j.issn.2095-3224.2021.06.014

经验交流

机器人辅助直肠癌切除经自然腔道取标本手术(NOSES)联合多脏器切除术的应用
武琦1, 陈伊教1, 朱德祥1,(), 韦烨1,(), 许剑民1   
  1. 1. 200032 上海,复旦大学附属中山医院普外科;200032 上海结直肠肿瘤微创工程技术研究中心;200032 复旦大学附属中山医院肿瘤防治中心
  • 收稿日期:2021-06-29 出版日期:2021-12-25
  • 通信作者: 朱德祥, 韦烨
  • 基金资助:
    国家自然科学基金面上项目(82072678); 上海市科委项目(19511121300); 上海申康医院发展中心临床三年行动计划资助(SHDC2020CR1033B,SHDC2020CR5006)

The application of robot-assisted natural orifice specimen extraction surgery in the combined with multiple organ resection in rectal cancer

Qi Wu1, Yijiao Chen1, Dexiang Zhu1,(), Ye Wei1,(), Jianmin Xu1   

  1. 1. Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China; Shanghai Engineering Research Cencer of Colorectal Cancer Minimally Invasive technology, Shanghai, 200032, China; Cancer center Zhongshan Hospital, Shanghai, 200032, China
  • Received:2021-06-29 Published:2021-12-25
  • Corresponding author: Dexiang Zhu, Ye Wei
引用本文:

武琦, 陈伊教, 朱德祥, 韦烨, 许剑民. 机器人辅助直肠癌切除经自然腔道取标本手术(NOSES)联合多脏器切除术的应用[J]. 中华结直肠疾病电子杂志, 2021, 10(06): 654-658.

Qi Wu, Yijiao Chen, Dexiang Zhu, Ye Wei, Jianmin Xu. The application of robot-assisted natural orifice specimen extraction surgery in the combined with multiple organ resection in rectal cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2021, 10(06): 654-658.

目的

探讨达芬奇机器人辅助直肠癌切除经自然腔道取标本手术(NOSES)联合多脏器切除术的安全性和可行性。

方法

回顾性收集2013年10月至2021年2月复旦大学附属中山医院结直肠外科收治的使用机器人辅助直肠癌NOSES手术患者的临床资料,选取术中进行多脏器联合切除的11例患者,分析其临床病理特征和围手术期相关结果。

结果

共有11例患者接受机器人辅助直肠癌NOSES手术联合多脏器切除术,其中男性2例(2/11),女性9例(9/11),平均年龄(56.0±11.2)岁,8例低位直肠癌(8/11),2例中位直肠癌(2/11),1例高位直肠癌(1/11)。术前合并糖尿病1例(1/11),高血压2例(2/11),冠心病1例(1/11)。全组患者均顺利完成机器人辅助直肠癌切除NOSES联合多脏器切除术,其中联合全子宫双附件切除4例,联合子宫切除术1例,联合小肠及全子宫双附件切除1例,联合肺转移灶切除1例,卵巢囊肿切除1例,胆囊切除1例,肝ALPPS手术1例,肝叶切除术1例。全组平均手术时间为(175.5±48.2)min,平均出血量为(33.6±19.1)mL。无中转开腹病例,全组无术中输血。所有患者上下切缘与环周切缘均为阴性。无围术期死亡。2例患者(2/11)发生术后并发症(1例小肠不全梗阻,1例肺部感染),均保守治疗后好转。术后平均排气时间(74.2±33.1)小时,术后平均住院时间为(5.9±0.9)天,术后平均辅助治疗开始时间为(18.3±5.4)日。术后病理TNM分期Ⅱ期2例(2/11),Ⅲ期4例(4/11),Ⅳ期5例(5/11)。

结论

有经验的外科团队在合适的直肠癌患者中施行机器人辅助直肠癌切除NOSES联合多脏器切除术安全可行。

Objective

To explore the safety and feasibility of Da Vinci robot-assisted natural orifice specimen extraction surgery (NOSES) for the combined resection of rectal cancer with multiple organs.

Methods

During October 2013 to February 2021, totally 11 patients undergoing this surgery in the department of colorectal surgery, Zhongshan Hospital of Fudan University were included into presented retrospective study. The analysis content includes the patient's baseline condition, surgery condition, postoperative condition and so on.

Results

Of the 11 patients in the whole group, included 2 males (2/11) and 9 females (9/11) with average age of (56.0±11.2) years, 8 low rectal cancer patients (8/11), 2 middle rectal cancer patients (2/11) and 1 high rectal cancer patients (1/11). One case (1/11) had diabetes mellitus, 2 cases (2/11) had hypertension and 1 case (1/11) had coronary heart disease. Whole group of patients were successfully completed robot assisted NOSES combined multiple organ resection of rectal cancer excision, which combined the uterus double appendix resection in 4 cases, combined hysterectomy in 1 case, combined the small intestine and the uterus double appendix resection in 1 case, combined lung metastases resection in 1 case, ovarian cyst resection in 1 case, cystic resection in 1 case, liver ALPPS surgery in 1 case, lobe resection in 1 case. The mean operation time was (175.5±48.2) min and the mean blood loss was (33.6±19.1) mL. No patient was transferred to laparotomy, and no intraoperative blood transfusion was found in the whole group. The upper and lower margins and circumferential margins were negative in all patients. There were no perioperative deaths. Postoperative complications occurred in 2 patients (2/11) (1 case intestinal insufficiency obstruction, 1 case pulmonary infection), all of which improved after conservative treatment. The mean postoperative exhaust time was (74.2±33.1) hours, the mean postoperative hospital stay was (5.9±0.9) days, and the mean postoperative adjuvant treatment start time was (18.3±5.4) days.Postoperative pathological TNM stages were stage Ⅱ in 2 patients (2/11), stage Ⅲ in 4 patients (4/11) and stage Ⅳ in 5 patients (5/11).

Conclusion

It is safe and feasible to perform robot-assisted NOSES multiple organ resection for eligible patients with rectal cancer under comprehensive evaluation.

[1]
Lu Z, Chen H, Zhang M, et al. Safety and survival outcomes of transanal natural orifice specimen extraction using prolapsing technique for patients with middle- to low-rectal cancer[J]. Chin J Cancer Res, 2020, 32(5): 654-664.
[2]
关旭, 王贵玉, 周主青, 等. 79家医院718例结直肠肿瘤经自然腔道取标本手术回顾性研究[J]. 中华结直肠疾病电子杂志, 2017, 6(6): 469-477.
[3]
Delaney CP, Lynch AC, Senagore AJ, et al. Comparison of robotically performed and traditional laparoscopic colorectal surgery[J]. Dis Colon Rectum, 2003, 46(12): 1633-1639.
[4]
中国医师协会结直肠肿瘤专业委员会机器人手术专业委员会, 中国研究型医院学会机器人与腹腔镜外科专业委员会. 机器人结直肠癌手术中国专家共识(2020版)[J]. 中华消化外科杂志, 2021, 20(1): 16-28.
[5]
Addison P, Agnew JL, Martz J. Robotic colorectal surgery[J]. Surg Clin North Am, 2020, 100(2): 337-360.
[6]
汤思哲, 王仆, 孔大陆. 达芬奇机器人手术系统结直肠癌根治术的现状和展望[J]. 中国肿瘤临床, 2019, 7(7): 370-374.
[7]
Chang TP, Chok AY, Tan D, et al. The emerging role of robotics in pelvic exenteration surgery for locally advanced rectal cancer: a narrative review[J]. J Clin Med, 2021, 10(7): 1518.
[8]
Pelvex Collaborative. Surgical and survival outcomes following pelvic exenteration for locally advanced primary rectal cancer: results from an international collaboration[J]. Ann Surg, 2019, 269(2): 315-321.
[9]
中华人民共和国国家卫生健康委员会. 中国结直肠癌诊疗规范(2020年版)[J]. 中华外科杂志, 2020, 58(8): 561-585.
[10]
王锡山. 结直肠肿瘤治疗的微创和功能外科理念在实践与探索中前行[J/CD]. 中华结直肠疾病电子杂志, 2013, 3(3): 106-108.
[11]
郑民华, 马君俊. 微创技术在结直肠肿瘤手术功能保护的优势与弊端[J]. 中华胃肠外科杂志, 2017, 20(6): 601-605.
[12]
Xu J, Tang B, Li T, et al. Robotic colorectal cancer surgery in China: a nationwide retrospective observational study[J]. Surg Endosc, 2020, 35(12): 6591-6603.
[13]
Milone M, Manigrasso M, Velotti N, et al. Completeness of total mesorectum excision of laparoscopic versus robotic surgery: a review with a meta-analysis[J]. Int J Colorectal Dis, 2019, 34(6): 983-991.
[14]
Zhou S, Wang X, Zhao C, et al. Comparison of short-term and survival outcomes for transanal natural orifice specimen extraction with conventional mini-laparotomy after laparoscopic anterior resection for colorectal cancer[J]. Cancer Manag Res, 2019, 1(11): 5939-5948.
[15]
王玉柳明, 张骞, 郁雷, 等. 结直肠肿瘤经自然腔道取标本手术203例回顾性研究[J/CD]. 中华结直肠疾病电子杂志, 2019, 8(1): 32-37.
[16]
Wolthuis AM, Fieuws S, Van Den Bosch A, et al. Randomized clinical trial of laparoscopic colectomy with or without natural-orifice specimen extraction[J]. Br J Surg, 2015, 102(6): 630-637.
[17]
牛正川, 韦烨, 朱德祥, 等. 机器人腹部无切口直肠癌前切除术[J/CD]. 中华结直肠疾病电子杂志, 2018, 7(4): 332-336.
[18]
Chen J, Zhang Z, Chang W, et al. Short-term and long-term outcomes in mid and low rectal cancer with robotic surgery[J]. Front Oncol, 2021, 9(11): 603073.
[19]
王锡山. 结肠直肠癌联合脏器切除若干问题思考[J]. 外科理论与实践, 2016, 21(6): 461-463.
[20]
Nanayakkara PR, Ahmed SA, Oudit D, et al. Robotic assisted minimally invasive pelvic exenteration in advanced rectal cancer: review and case report[J]. J Robot Surg, 2014, 8(2): 173-175.
[21]
Heah NH, Wong KY. Feasibility of robotic assisted bladder sparing pelvic exenteration for locally advanced rectal cancer: A single institution case series[J]. World J Gastrointest Surg, 2020, 12(4): 190-196.
[22]
Raj Kumar B, Bankar S, Pandey D, et al. Abdominoperineal excision with prostatectomy in T4 rectal cancer - bladder-sparing robotic pelvic exenteration - a video vignette[J]. Colorectal Dis, 2020, 22(11): 1786-1787.
[23]
Shin US, Nancy You Y, Nguyen AT, et al. Oncologic outcomes of extended robotic resection for rectal cancer[J]. Ann Surg Oncol, 2016, 23(7): 2249-2257.
[24]
Mañas MJ, Espín E, López-cano M, et al. Multivisceral resection for locally advanced rectal cancer: prognostic factors influencing outcome[J]. Scand J Surg, 2015, 104(3): 154-160.
[25]
Kim KY, Hwang DW, Park YK, et al. A single surgeon's experience with 54 consecutive cases of multivisceral resection for locally advanced primary colorectal cancer: can the laparoscopic approach be performed safely?[J]. Surg Endosc, 2012, 26(2): 493-500.
[26]
Hino H, Yamaguchi T, Kinugasa Y, et al. Robotic-assisted multivisceral resection for rectal cancer: short-term outcomes at a single center[J]. Tech Coloproctol, 2017, 21(11): 879-886.
[27]
姜勇, 吴涛, 万远廉, 等. cT4bM0期原发直肠癌的外科治疗及预后分析[J]. 中华消化外科杂志, 2013, 6(6): 417-421.
[1] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[2] 代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[3] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[4] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[5] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[6] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[7] 罗佳, 赵晶晶, 曹小珍, 钟玲, 范林军, 曾令娟. 单侧腋窝双侧乳晕入路机器人甲状腺术后局部加压预防皮下隧道出血的对照研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 603-606.
[8] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[9] 付振保, 曹万龙, 刘富红. 腹腔镜直肠癌低位前切除术中不同缝合方法的回肠双腔造口术临床效果研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 684-687.
[10] 贺亮, 王松林, 周业江. 两种预防性回肠造口在腹腔镜ISR术治疗超低位直肠癌的效果对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 697-700.
[11] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[12] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[13] 张继新, 胡军红, 谢爽, 武祖印, 张春旭. 经阴道单孔腹腔镜阑尾切除术可行性及近期疗效分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 460-465.
[14] 卢艳军, 马健, 白鹏宇, 郭凌宏, 刘海义, 江波, 白文启, 张毅勋. 纳米碳在腹腔镜直肠癌根治术中253组淋巴结清扫的临床效果[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 473-477.
[15] 李博, 胡刚, 邱文龙, 汤坚强, 王锡山. 多功能吲哚菁绿近红外荧光血管成像技术在腹腔镜直肠癌经自然腔道取标本手术(NOSES Ⅳ式)中的应用(附视频)[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 524-528.
阅读次数
全文


摘要